Medication info
Olmetan Tablet 40 mg (Olmesartan Medoxomil)

Olmetan Tablet 40 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202002233 · Approved 2020.03.31 · Insurance code 060500660

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose while the patient's condition is carefully monitored. <Elderly patients> No dosage adjustment is required when administering this drug to elderly patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is required in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use of this drug is not recommended in patients with severe hepatic impairment because there is no experience with its use in this population.
Child dose
<Pediatrics> Safety and efficacy in children have not been established.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure, which requires treatment to prevent long-term cardiovascular diseases. This medication effectively lowers the blood pressure in essential hypertension, helping to reduce the burden on the cardiovascular system. By controlling blood pressure, it decreases the risk of complications such as myocardial infarction and stroke, and improves overall health. We will guide the appropriate dosage and administration method based on the patient's condition, and regular intake is important. Treatment effects can be enhanced when combined with lifestyle improvements. It is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose while the patient's condition is carefully monitored. <Elderly patients> No dosage adjustment is required when administering this drug to elderly patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is required in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use of this drug is not recommended in patients with severe hepatic impairment because there is no experience with its use in this population.

Child dose

<Pediatrics> Safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it must be discontinued immediately if pregnancy is confirmed. Those allergic to any components of this medication, pregnant or breastfeeding individuals, those undergoing kidney dialysis, individuals with severe liver dysfunction, and those with biliary obstruction should not take this medication. Additionally, individuals with lactose intolerance or specific genetic conditions should also avoid using this medication. Patients with low blood volume or low sodium may experience hypotension when starting this medication, so their condition should be carefully monitored before administration. If hypotension occurs, appropriate measures should be taken. Patients with impaired kidney function or those who have received a kidney transplant, patients with renovascular hypertension, or patients at risk of hyperkalemia should periodically monitor their kidney function and potassium levels while taking this medication, and adjustments should be made according to the physician’s instructions if necessary. Patients with aortic stenosis, mitral valve stenosis, obstruction, or hypertrophic heart disease should exercise caution when using this medication. This medication can cause dizziness due to its blood pressure-lowering effect, so dangerous activities such as high-altitude work or operating vehicles should be avoided. While on this medication, taking potassium-sparing diuretics or potassium supplements can elevate blood potassium levels, so caution is warranted. Taking it with other antihypertensive medications may increase the blood pressure-lowering effect, so consult a physician. Co-administration with lithium may lead to elevated lithium levels and toxicity, so this combination is not recommended. Using non-steroidal anti-inflammatory drugs concurrently may worsen kidney function, necessitating periodic monitoring of kidney function. Administering this medication to pregnant individuals can result in serious harm to the fetus, so it must not be taken during pregnancy, and if pregnancy is suspected, it should be discontinued immediately. Breastfeeding women should note that this medication can be transmitted through breast milk, and it is advisable to either discontinue breastfeeding or stop taking this medication. The safety and efficacy in children have not yet been established, so children should not take this medication. Elderly patients may have increased concentrations of this medication in their bodies, so care should be exercised when administering it. In cases of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur; seek medical assistance immediately in such instances. No evidence of carcinogenicity or genotoxicity was found with long-term use of this medication; however, rare side effects such as liver dysfunction or vascular edema may occur, so consult healthcare professionals if any unusual symptoms appear.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 43 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute kidney failure
  • increased serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • positional dizziness
  • palpitations
  • increased blood pressure
  • elevated serum creatinine
  • epistaxis
  • upper respiratory infection
  • asthma
  • hypotension
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1°C and 25°C, in a cool place.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.